[Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
Ertl
G
G
Medizinische Klinik, Universität Würzburg. Ertl_G@klinik.uni-wuerzburg.de
Nitschmann
S
S
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002227:Carbazoles / Q000009:adverse effects / Q000627:therapeutic use*; D000077261:Carvedilol; D002423:Cause of Death; D002908:Chronic Disease; D004311:Double-Blind Method; D005060:Europe; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008790:Metoprolol / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D011412:Propanolamines / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D008790:Metoprolol